C. Matthies

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study

A. Hiester, T. Buchler, U. Pichlmeier, 2022, Therapeutic advances in medical oncology.